Comorbidity prevalence and healthcare costs in people living with HIV compared with the general population: a 19-year retrospective cohort study in British Columbia, Canada

Objectives Our objectives were (1) to characterise the age-sex-standardised prevalence of comorbidities among people living with HIV (PLWH) and people not living with HIV (PnLWH) between 2001 and 2019 and (2) to examine the effect of comorbidities on direct healthcare costs among PLWH and PnLWH.Desi...

Full description

Saved in:
Bibliographic Details
Main Authors: Robert S Hogg, Silvia Guillemi, Viviane D Lima, Hasan Nathani, Carly Magee, Michael Budu, Morris Chan, Bronhilda Takeh, Katherine W Kooij, Julio G S Montaner
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/7/e099263.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850102804753940480
author Robert S Hogg
Silvia Guillemi
Viviane D Lima
Hasan Nathani
Carly Magee
Michael Budu
Morris Chan
Bronhilda Takeh
Katherine W Kooij
Julio G S Montaner
author_facet Robert S Hogg
Silvia Guillemi
Viviane D Lima
Hasan Nathani
Carly Magee
Michael Budu
Morris Chan
Bronhilda Takeh
Katherine W Kooij
Julio G S Montaner
author_sort Robert S Hogg
collection DOAJ
description Objectives Our objectives were (1) to characterise the age-sex-standardised prevalence of comorbidities among people living with HIV (PLWH) and people not living with HIV (PnLWH) between 2001 and 2019 and (2) to examine the effect of comorbidities on direct healthcare costs among PLWH and PnLWH.Design This was a retrospective, matched cohort study conducted with the Comparative Outcomes and Service Utilisation Trends (COAST) cohort, which contained all known PLWH in British Columbia (BC), Canada and a general population sample.Setting BC, Canada.Participants A total of 9554 PLWH and 47 770 PnLWH from the COAST cohort were followed between 2001 and 2019. Participants were at least 19 years old and 82% male in both groups.Outcome measures The primary outcomes were the age-sex-standardised prevalence of 16 comorbidities, calculated annually, among PLWH and PnLWH. Secondary outcomes included direct healthcare costs associated with each comorbidity among PLWH and PnLWH. Outcomes were ascertained from administrative health databases.Results PLWH exhibited a higher age-sex-standardised prevalence of most comorbidities compared with PnLWH over the study period. Relative disparities in liver and kidney diseases markedly decreased since 2008. Disparities in the prevalence of mental health disorders and substance use disorder (SUD) were consistently large throughout the study period. Comorbidities were associated with high healthcare costs, especially among PLWH.Conclusions This study underscores the persistent and evolving burden of non-AIDS-defining comorbidities among PLWH, even in the context of improved HIV management. The high prevalence of mental health disorders and SUD, coupled with the substantial healthcare costs associated with these conditions, emphasises the need for holistic and integrated care models that address the full spectrum of health challenges faced by PLWH.
format Article
id doaj-art-27d6624c845d43b19c8adab0593403eb
institution DOAJ
issn 2044-6055
language English
publishDate 2025-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-27d6624c845d43b19c8adab0593403eb2025-08-20T02:39:41ZengBMJ Publishing GroupBMJ Open2044-60552025-07-0115710.1136/bmjopen-2025-099263Comorbidity prevalence and healthcare costs in people living with HIV compared with the general population: a 19-year retrospective cohort study in British Columbia, CanadaRobert S Hogg0Silvia Guillemi1Viviane D Lima2Hasan Nathani3Carly Magee4Michael Budu5Morris Chan6Bronhilda Takeh7Katherine W Kooij8Julio G S Montaner9British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, CanadaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, CanadaObjectives Our objectives were (1) to characterise the age-sex-standardised prevalence of comorbidities among people living with HIV (PLWH) and people not living with HIV (PnLWH) between 2001 and 2019 and (2) to examine the effect of comorbidities on direct healthcare costs among PLWH and PnLWH.Design This was a retrospective, matched cohort study conducted with the Comparative Outcomes and Service Utilisation Trends (COAST) cohort, which contained all known PLWH in British Columbia (BC), Canada and a general population sample.Setting BC, Canada.Participants A total of 9554 PLWH and 47 770 PnLWH from the COAST cohort were followed between 2001 and 2019. Participants were at least 19 years old and 82% male in both groups.Outcome measures The primary outcomes were the age-sex-standardised prevalence of 16 comorbidities, calculated annually, among PLWH and PnLWH. Secondary outcomes included direct healthcare costs associated with each comorbidity among PLWH and PnLWH. Outcomes were ascertained from administrative health databases.Results PLWH exhibited a higher age-sex-standardised prevalence of most comorbidities compared with PnLWH over the study period. Relative disparities in liver and kidney diseases markedly decreased since 2008. Disparities in the prevalence of mental health disorders and substance use disorder (SUD) were consistently large throughout the study period. Comorbidities were associated with high healthcare costs, especially among PLWH.Conclusions This study underscores the persistent and evolving burden of non-AIDS-defining comorbidities among PLWH, even in the context of improved HIV management. The high prevalence of mental health disorders and SUD, coupled with the substantial healthcare costs associated with these conditions, emphasises the need for holistic and integrated care models that address the full spectrum of health challenges faced by PLWH.https://bmjopen.bmj.com/content/15/7/e099263.full
spellingShingle Robert S Hogg
Silvia Guillemi
Viviane D Lima
Hasan Nathani
Carly Magee
Michael Budu
Morris Chan
Bronhilda Takeh
Katherine W Kooij
Julio G S Montaner
Comorbidity prevalence and healthcare costs in people living with HIV compared with the general population: a 19-year retrospective cohort study in British Columbia, Canada
BMJ Open
title Comorbidity prevalence and healthcare costs in people living with HIV compared with the general population: a 19-year retrospective cohort study in British Columbia, Canada
title_full Comorbidity prevalence and healthcare costs in people living with HIV compared with the general population: a 19-year retrospective cohort study in British Columbia, Canada
title_fullStr Comorbidity prevalence and healthcare costs in people living with HIV compared with the general population: a 19-year retrospective cohort study in British Columbia, Canada
title_full_unstemmed Comorbidity prevalence and healthcare costs in people living with HIV compared with the general population: a 19-year retrospective cohort study in British Columbia, Canada
title_short Comorbidity prevalence and healthcare costs in people living with HIV compared with the general population: a 19-year retrospective cohort study in British Columbia, Canada
title_sort comorbidity prevalence and healthcare costs in people living with hiv compared with the general population a 19 year retrospective cohort study in british columbia canada
url https://bmjopen.bmj.com/content/15/7/e099263.full
work_keys_str_mv AT robertshogg comorbidityprevalenceandhealthcarecostsinpeoplelivingwithhivcomparedwiththegeneralpopulationa19yearretrospectivecohortstudyinbritishcolumbiacanada
AT silviaguillemi comorbidityprevalenceandhealthcarecostsinpeoplelivingwithhivcomparedwiththegeneralpopulationa19yearretrospectivecohortstudyinbritishcolumbiacanada
AT vivianedlima comorbidityprevalenceandhealthcarecostsinpeoplelivingwithhivcomparedwiththegeneralpopulationa19yearretrospectivecohortstudyinbritishcolumbiacanada
AT hasannathani comorbidityprevalenceandhealthcarecostsinpeoplelivingwithhivcomparedwiththegeneralpopulationa19yearretrospectivecohortstudyinbritishcolumbiacanada
AT carlymagee comorbidityprevalenceandhealthcarecostsinpeoplelivingwithhivcomparedwiththegeneralpopulationa19yearretrospectivecohortstudyinbritishcolumbiacanada
AT michaelbudu comorbidityprevalenceandhealthcarecostsinpeoplelivingwithhivcomparedwiththegeneralpopulationa19yearretrospectivecohortstudyinbritishcolumbiacanada
AT morrischan comorbidityprevalenceandhealthcarecostsinpeoplelivingwithhivcomparedwiththegeneralpopulationa19yearretrospectivecohortstudyinbritishcolumbiacanada
AT bronhildatakeh comorbidityprevalenceandhealthcarecostsinpeoplelivingwithhivcomparedwiththegeneralpopulationa19yearretrospectivecohortstudyinbritishcolumbiacanada
AT katherinewkooij comorbidityprevalenceandhealthcarecostsinpeoplelivingwithhivcomparedwiththegeneralpopulationa19yearretrospectivecohortstudyinbritishcolumbiacanada
AT juliogsmontaner comorbidityprevalenceandhealthcarecostsinpeoplelivingwithhivcomparedwiththegeneralpopulationa19yearretrospectivecohortstudyinbritishcolumbiacanada